相关实验视频
Updated: Jun 20, 2025

The Soft Agar Colony Formation Assay
Published on: October 27, 2014
哺乳动物SWI/SNF复合体活性调节POU2F3并构成小细胞肺癌中可向的依赖性
Leslie Duplaquet1, Kevin So2, Alexander W Ying3
1Department of Medical Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02215, USA.
POU2F3阳性小细胞肺癌 (SCLC) 依赖mSWI/SNF复合体进行生长. 抑制这些复合物,包括非正规的BAF (ncBAF),表明作为这种SCLC亚型的新治疗策略具有前途.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 遗传学 是一个
背景情况:
- 小细胞肺癌 (SCLC) 由ASCL1,NEUROD1和POU2F3.3.等转录因子定义的异质亚型组成.
- 具有POU2F3阳性SCLC,约占病例的12%,对POU2F3转录因子表现出特定的依赖.
研究的目的:
- 通过基因组尺度屏幕识别POU2F3表达和SCLC增殖的调节者.
- 探索mSWI/SNF复合物作为POU2F3阳性SCLC的潜在治疗点.
主要方法:
- 基因组尺度屏幕用于识别POU2F3表达和SCLC增殖的调节者.
- 化学破坏mSWI/SNF ATPase活动和BRD9降解.
- 使用临床级药理学药剂的体内研究,针对SMARCA4/2 ATPases和BRD9.9.
主要成果:
- 确定mSWI/SNF复合体是对POU2F3阳性SCLC特有的关键依赖性.
- 抑制mSWI/SNF ATPase活性减少了所有POU2F3阳性SCLCs中的增殖.
- 在纯非神经内分泌POU2F3-SCLC中,BRD9降解有效向非正规BAF (ncBAF).
- mSWI/SNF复合体调节POU2F3介导网络中的基因可访问性.
- 药理抑制降低了瘤生长,并在体内增加了生存率.
结论:
- mSWI/SNF复合体是SCLC中POU2F3致癌计划的核心.
- 针对mSWI/SNF复合体,包括ncBAF,代表POU2F3阳性SCLC的一个有前途的治疗策略.
更多相关视频
10:21Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
Published on: September 20, 2024
07:34The Power of Simplicity: Sea Urchin Embryos as in Vivo Developmental Models for Studying Complex Cell-to-cell Signaling Network Interactions
Published on: February 16, 2017
相关概念视频
Regulation of Nuclear Protein Sorting
PI3K/mTOR/AKT Signaling Pathway
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Abnormal Proliferation
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...